Subscribe to Newsletter

Digital Technologies

Discovery & Development Clinical Trials

Clinical Trials and Digital Doubles

| 5 min read

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

Business & Regulation Digital Technologies

The Changing Landscape of Decentralized Clinical Trials

| Diane Leclerc | 2 min read

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

Business & Regulation Business Practice

Why Pharma Must Embrace AI and Open Source

| Brendan Frey | 4 min read

With open minds and open sources, the future is foundational – and bright.

Discovery & Development Drug Discovery

The Speed of Success

| 4 min read

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

Manufacture Advanced Medicine

Advanced Transformation

| 7 min read

Software development and CDMO experts share their key tips for choosing the right digital technologies and partnerships

Manufacture Advanced Medicine

The Digital Dream

| Alexander Seyf | 4 min read

Digitalization can transform the operation and performance of the cell and gene therapy manufacturing space, to the benefit of all.

Business & Regulation Digital Technologies

Industry 4.0 in Action

| Balajikasiram Sundararajan | 6 min read

A company shares their experience with Industry 4.0 – including the types of digital technologies implemented and the benefits being seen.

Discovery & Development Drug Discovery

Predictive AI in Drug Discovery: Five Steps to Success

| Mirit Eldor | 5 min read

The use of AI in small molecules drug discovery is driving the sector in big ways – but there are big challenges too. Here are five steps to success

Discovery & Development Clinical Trials

The Art of Prescreening

| 5 min read

How does prescreening improve clinical trials? Cara Brant, CEO of Clinical Trial Media, explains.

Discovery & Development Drug Discovery

APIs from the Algorithm

| Stephanie Vine | 2 min read

DRAGONFLY deep learning meets de novo drug design – and Roche has already tested the approach

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register